As Abdi İbrahim continues to expand its oncology portfolio and leverage its position as a leading pharma player in Turkey and beyond, we see a strong mutual fit in the upcoming Ribociclib API opportunity. With the market heading toward patent expiry and strong demand from the CDK4/6 class, we believe our supply solution can support your development and future commercial needs.

Unibest Industrial Co., Ltd. offers Ribociclib (UBX11) API with full GMP compliance, DMF/CEP/ASMF readiness, tight nitrosamine control, and scalable supply from early clinical to commercial volumes. Our robust manufacturing capacity ensures a reliable, long-term source of this high-value molecule. Additionally, our broad portfolio covers both chemical and biological ingredients, many with established EU/TGA/FDA-accepted filing experience, giving you a one-stop supply base for multiple API needs.

Could we schedule a short call to discuss your current Ribociclib project timeline and registration requirements? We would be pleased to provide a detailed dossier, CoA, or samples for your technical review.

I can help with that! However, I don’t have direct access to live date and time information in this format. Based on my system’s internal clock, the current date and time is:

Wednesday, January 21, 2026, 17:07 UTC.

If you’d like the time in a specific timezone, feel free to tell me where you are, and I can convert it for you!